Global Mechanical Circulatory Support (MCS) Devices Market : Global Market Estimation, Dynamics, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Global Mechanical Circulatory Support (MCS) Devices Market: By Indication (By Listed to Transplant, Bridge to Candidacy, Destination Therapy (DT), and Others), By Device (IABPs, Impella, VA-ECLS, and LVADs), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global mechanical circulatory support (MCS) devices market estimated to be valued US$ 2500 Mn in 2021 and projected to grow at significant CAGR of 11.3% over 2022-2028 to reach USD 5289.40 Mn by 2028. Based on device type, Left ventricular assist devices LVADs (HeartMate, HeartWare, TandemLife, and Others) has the highest market share that constitutes almost xx% of the overall market growing with a CAGR of xx% owing to advancements in the technology that can be used in various indications such as BTT, BTR, and  DT, among others. Impella (Abiomed) has registered the highest growth rate over the historic years with a CAGR of xx% to reach US$ xx Mn in 2018 owing to expansion of Impella in European and Asia Pacific region in countries such as Japan, Australia, among others. Global market report gives comprehensive outlook on mechanical circulatory support (MCS) devices across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, and Rest of the World. This report studies global dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global mechanical circulatory support (MCS) devices market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global mechanical circulatory support (MCS) devices products

Mechanical Circulatory Support (MCS) Devices Market

MARKET SUMMARY
-
11.3% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 11.3%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Mechanical Circulatory Support (MCS) Device Market

  • The report on global Mechanical Circulatory Support (MCS) Device Market gives historical, current, and future market sizes (US$ Mn) on the basis of indication, device type and geography.
  • Mechanical Circulatory Support (MCS) Device Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa
Key Players
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Cardiac Assist, Inc.
  • Cardio Bridge GmbH
  • Carmat SA
Dynamics

Mechanical Circulatory Support (MCS) Devices Market

Increasing prevalence of heart diseases coupled with favorable reimbursement policies available and shortage of heart donors are the major factors driving the growth of the market. Moreover, development and advancements in technology is playing major role in the growth of the mechanical circulatory support (MCS) devices market. However, product recalls and complications associated with mechanical circulatory support devices hinders the growth of the market.


North-America got significant share

Mechanical Circulatory Support (MCS) Devices Market

North America accounted for larger revenue share in global mechanical circulatory support (MCS) devices market with significant CAGR owing to increasing number of heart transplants and adoption of new technologies in the region coupled with the availability of healthcare reimbursement policies and an increasing FDA approvals for the devices for new indications. Europe and Japan are expected to show significant growth over the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Mechanical Circulatory Support (MCS) Devices Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Cardiac Assist, Inc.
  • Cardio Bridge GmbH
  • Carmat SA
  • Evaheart USA, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Getinge AB
  • Medtronic
  • Abbott Laboratoris

Description

The global mechanical circulatory support (MCS) devices market estimated to be valued US$ 2500 Mn in 2021 and projected to grow at significant CAGR of 11.3% over 2022-2028 to reach USD 5289.40 Mn by 2028. Based on device type, Left ventricular assist devices LVADs (HeartMate, HeartWare, TandemLife, and Others) has the highest market share that constitutes almost xx% of the overall market growing with a CAGR of xx% owing to advancements in the technology that can be used in various indications such as BTT, BTR, and  DT, among others. Impella (Abiomed) has registered the highest growth rate over the historic years with a CAGR of xx% to reach US$ xx Mn in 2018 owing to expansion of Impella in European and Asia Pacific region in countries such as Japan, Australia, among others. Global market report gives comprehensive outlook on mechanical circulatory support (MCS) devices across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, and Rest of the World. This report studies global dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global mechanical circulatory support (MCS) devices market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global mechanical circulatory support (MCS) devices products

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX